Rexhepi Sylejman, Rexhepi Mjellma, Sahatçiu-Meka Vjollca, Pllana Ejup, Dragusha Gani, Gashi Masar, Rexhepi Blerta
Faculty of Medicine, University of Pristina, Rr. "Bulevardi i dëshmorëve" p.n., 10000 Pristina, Kosovo.
Reumatizam. 2009;56(2):77-80.
The paper presents the results of studies of acute phase reactants in the 60 treated patients with rheumatoid arthritis. Patients were divided into two groups, depending on the applied treatment: group I (n = 30) was treated with methotrexate, sulfasalazine and hydroxychloroquine, and group II (n = 30) with methotrexate. The results of our study shows that there is a statistically significant reduction in the value of acute phase reactants and clinical parameters after treatment in both investigated groups of patients, and also a significant statistical difference between the first and second group of treated patients.
